MarketWatch

Hi-Tech Pharma shares fall as company swings to a loss

SAN FRANCISCO (MarketWatch) -- Hi-Tech Pharmacal Co. shares fell 29% to $14.05 Thursday morning after the Amityville, N.Y.-based company reported a first-quarter net loss of $959,000, or 8 cents a ...
Business Wire

Model N Spring 2023 Release Introduces 340B Vigilance Solution for Pharma; Enhances Global Tendering for Life Sciences and Increases Business Agility for High-Tech Customers

SAN MATEO, Calif.--(BUSINESS WIRE)--Model N (NYSE: MODN), the leader in revenue optimization and compliance, today announced its Spring 2023 product release for life sciences and high-tech customers.
Newsday

Competing generic pressures Hi Tech Pharma shares

Amityville-based Hi-Tech Pharmacal Co. Inc.'s share price fell sharply by mid-day Tuesday, by more than 15 percent, after news that a Mumbai, India, firm had received approval for a competing generic ...
Reuters

Hi-Tech Pharma receives tentative approval for Calcipotriene topical solution

Co announces the FDA granted tentative approval to the co's Abbreviated New Drug Application for Calcipotriene topical solution, 0.005%. Hi-Tech's Calcipotriene topical solution is the generic ...
Reuters

Hi-Tech Pharma sells rights to Naprelan Extended release tablets to Victory Pharma

Co announces that it entered into an agreement with Victory Pharma to market and distribute Naprelan extended release tablets, with the ultimate goal of selling the Naprelan asset. Effective April 30, ...